Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Next Pharmaceuticals Gains Formula & Intellectual Property for Sytrinol - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Next Pharmaceuticals Gains Formula & Intellectual Property for Sytrinol

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Next Pharmaceuticals, Salinas, CA, has purchased worldwide distribution rights, along with all patents, trademarks and scientific knowledge for Sytrinol from KGK Synergize, London, ON. Sytrinol is currently sold through Proprietary Nutritionals Inc., Kearny, NJ, who holds distribution rights through December 31, 2013.
 
Sytrinol is a patented and proprietary formula derived from natural citrus and palm fruit extracts. It combines polymethoxylated flavones (PMFs) and delta, gamma, and alpha tocotrienols.
 
Clinical research has demonstrated that Sytrinol significantly aids in improving total cholesterol, LDL-cholesterol, and triglycerides up to 30%, 27%, and 34%, respectively, compared to placebo. Sytrinol has also been shown to increase HDL-cholesterol and is a powerful antioxidant. The ingredient has been granted self-affirmed GRAS (Generally Recognized as Safe) status. 

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics